Transforming the management
of Mycobacterial diseases

Twitter Youtube Linkedin Envelope
Actiphage TB awarded US Patent grant for diagnostic kit
Read more
Actiphage TB awarded US Patent grant for diagnostic kit
“Significant association between positive Actiphage test and features of progressive TB infection.”
Read more
Lancet article - PET-CT features observed following M tuberculosis exposure. biomarkers show those at high risk of TB

Actiphage – Confidence
to test for active TB

Loading...

 

PBD Biotech – developers of Actiphage®, a novel bacteriophage-based diagnostic.

Actiphage rapidly and accurately detects and identifies live mycobacteria – the pathogen that causes human tuberculosis, bovine tuberculosis and Johne’s Disease – from a sample of blood or milk.

Actiphage offers the potential for effective detection, management, and eradication of these diseases.

Please contact us if you would like to discuss this further or to use the testing service.

PBD Biotech developers of Actiphage TB

Rapid blood test for Johne’s now available – enquire here 

Latest

Loading...
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase
May 12, 2023
The UK’s first Centre for Phage Research officially launched on 16th May 2023 and featured in the UK KTN UK Phage Innovation Showcase will be Actiphage®, a phage-based molecular diagnostic for tuberculosis.
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase
May 12, 2023
The UK’s first Centre for Phage Research officially launched on 16th May 2023 and featured in the UK KTN UK...
1 2